Ohio's new recreational marijuana law has ignited a political firestorm, leaving residents in a hazy limbo. While adults can legally possess and cultivate cannabis at home, the lack of a legal purchasing system has created frustration.
What Happened: While Governor DeWine warns of an illicit market, the House of Representatives has implied it will not address the issue until February, prompting accusations of stalling for political reasons.
The GOP-dominated Senate, eager to quell DeWine's illicit market concerns, proposed a temporary measure allowing sales to take place at medical marijuana dispensaries as of December 7, one month after the November 7 legalization vote. However, the Republican bill came with strings attached: slashed home-grow limits, reduced THC potency and a very different view of how cannabis revenue should be spent.
Republican Representative Jamie Callender, the de facto spokesman for the House, balked. "This undermines the will of the voters," he said, effectively slamming the brakes on the Senate's proposal.
DeWine, preparing for the House's upcoming session wherein the body will likely override his veto on a transgender healthcare ban, responded snidely. "Perhaps they could also take up the marijuana issue," he said in an interview with WSYX, a local ABC outlet. "I have a sense of urgency of our need to really get something done." The House has indicated that its first matter at hand is going after the governor’s veto, which leaves Ohio's cannabis program on hold or as DeWine said, "a mess."
Callender said he would insist on protecting the voters' mandate as put forward in the original initiative, which passed with 57% of the vote. In a proposed bill of his own, very similar to the existing law, he adds safeguards for advertising and children's access. He also advocates for immediate cannabis sales to begin at existing medical marijuana dispensaries, aiming to strike a balance between public safety and voter intent.
"Let's not forget this is the People's House. We must carry out the will of the people, and the people have spoken," Callendar said.
Image AI created
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.